Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Yxneskär Bioteknik AB
AB
Active
Org 5592468614
Reutersgatan 4 1502
Engineering activities and related technical consultancy · NACE 7112
Est. 2020
0 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2025
SEK 190K
-90% vs 2024
EBITDA margin
53.4%
-93% vs 2024
Equity ratio
98.0%
Financial strength
Net profit 2025
SEK 238K
-81% vs 2024
EBITDA — year on year
SEK millions
4M
3M
2M
1M
0M
0M
2021
2M
+200%
2022
3M
+50%
2023
2M
-33%
2024
0M
-100%
2025
Key figures
Annual report 2025
Revenue
SEK 190K
-90%
EBITDA
SEK 102K
-93%
Net profit
SEK 238K
-81%
Total assets
SEK 5M
+1%
Equity
SEK 4,9M
+1%
Employees
0
—
Company information
Legal name
Yxneskär Bioteknik AB
Org number
5592468614
Legal form
Aktiebolag
NACE code
7112 · Engineering activities and related technical consultancy
Founded
9 mars 2020
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-03-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Aktiebolaget ska bedriva verksamhet inom marknadsföring och utveckling av kemi- och bio-baserade tekniska lösningar, huvudsakligen på konsultbasis.
Contact
Address
Reutersgatan 4 1502
Email
per.svending@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Engineering activities and related technical consultancy
Companies in Tjörn
All Sweden companies
Revenue
SEK millions
0M
1M
2M
3M
3M
0M
2021
2M
2022
3M
2023
2M
2024
0M
2025
EBITDA
SEK millions
0M
1M
2M
3M
3M
0M
2021
2M
2022
3M
2023
2M
2024
0M
2025
Income statement
SEK thousands
Item
2021
2022
2023
2024
2025
Revenue
0
2 377
3 407
1 853
190
Staff expenses
—
—
—
−54
−7
EBITDA
−22
2 221
3 028
1 553
102
Depreciation & amort.
−0
−0
−0
—
—
EBIT
−22
2 221
3 028
1 553
102
Net financials
—
—
6
60
200
Profit before tax
−22
2 221
3 033
1 613
302
Tax
−0
−412
−625
−334
−64
Net profit
−22
1 809
2 408
1 279
238
Balance sheet
SEK thousands
Item
2021
2022
2023
2024
2025
Total assets
74
1 827
3 826
4 971
5 039
Equity
28
1 837
3 826
4 910
4 939
Long-term debt
50
0
0
—
—
Short-term debt
4
10
0
61
101
Total debt
54
10
—
61
101
Financial ratios
5-year trend
EBITDA margin
53.4%
This company
15.8%
Market median
+238% vs market
2021
2025
Equity ratio
98.0%
This company
38.2%
Market median
+157% vs market
2021
2025
Return on equity
4.8%
This company
18.4%
Market median
-74% vs market
2021
2025
Net profit margin
124.9%
This company
8.1%
Market median
+1442% vs market
2021
2025
Asset turnover
0.04×
This company
1.12×
Market median
-96% vs market
2021
2025
Debt / equity
0.02×
This company
0.62×
Market median
+97% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2024-04-01 – 2025-03-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2023-04-01 – 2024-03-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2022-04-01 – 2023-03-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2021-04-01 – 2022-03-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2020-03-01 – 2021-03-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (1)
PJ
Per Johan Svending
Chief Executive Officer
Chief Executive Officer
2022
Board of directors
Non-executive oversight
Name
Role
Member since
Current (1)
LK
Lene Kristine Schack
Deputy Board Member
2022
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of Yxneskär Bioteknik AB also hold positions in
0
other companies.
Person
Role here
Other companies
Per Johan Svending
Chief Executive Officer
0 companies
Lene Kristine Schack
Deputy Board Member
0 companies